Ancient Humans Evolved New Blood Types After Leaving Africa

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
AHB-Lab_Blogs-Cover-20250124

Table of Contents

Unveiling the Evolution of Blood Groups

From a gene’s-eye view, blood types are so much more than the markers for transfusions; they act like an intricate map of human evolution and immune adaptation. A new genetic study, recently published in Scientific Reports, shines light on how blood types came to be in early modern humans and Neanderthals. It exposes how such variations helped ancient humans adapt to new environments and pathogens while out of Africa. The findings also highlight intriguing links between ancient blood groups and the genetic legacy that humans inherited from Neanderthals.

 

Blood Types: A Defense Against Disease

ABO blood types refer to the types of immune proteins on the surface of red blood cells, and each type has associated strengths and weaknesses regarding resistance to specific pathogens. People with type O blood are at an advantage in areas where the most virulent forms of malaria are common, but they are at greater risk from cholera. In human history, infectious disease has been a potent agent of natural selection that has shaped the population distribution of ABO blood types.

 

The Genetic Origins of Blood Types

To trace the origins of the blood types, scientists have now examined the ancient DNA of 22 Homo sapiens who lived between 46,000 and 16,500 years ago, 14 Neanderthals, and one Denisovan-Neanderthal hybrid. These samples from archaeological sites around Europe and Asia allow a view into how the blood types evolved when early humans migrated and interacted with various environments.

Neanderthal Blood Groups: A Static Legacy

The results of the study put forward that Neanderthal blood groups did not change much in the last 80,000 years of their existence. This lack of variation reflects their small, isolated populations, which had limited genetic diversity. Despite mingling with other hominin groups, Neanderthals maintained a stable blood group profile until their extinction around 40,000 years ago.

 

How Blood Types Evolved in Homo Sapiens

In contrast to Neanderthals, early modern humans showed remarkable genetic variation in blood groups. New genetic variants determining blood types emerged as Homo sapiens migrated out of Africa between 70,000 and 45,000 years ago. This diversity was driven by encounters with novel pathogens and environmental pressures.

A “Genetic Incubator” in the Persian Plateau

A genetic incubator: that was the role played by the Persian Plateau, the research study said. Migrating Homo sapiens spent almost 15,000 years going through the plateau, based on various archaeological records. This, over a period of time, established genetic mutations resulting in the emergence of new blood types within the migrant population. Once the resumption of journey to other parts of Eurasia was ensured for these humans, the same genes travelled, gradually acquiring immunities against different kinds of diseases.

The RHD DIII Type 4 Variant: A Neanderthal Contribution

The study also turned up evidence of interbreeding between early modern humans and Neanderthals. One such rare blood group variant, known as RHD DIII type 4, has its origins in Neanderthals and was donated to modern humans when the latter migrated into Southeast Asia more than 65,000 years ago. Such a variant would probably have given a good evolutionary advantage to humans in order to live and reproduce in alien environments. This condition also has modern implications in the fact that if a mother and baby have a mismatched blood type, pregnancy complications can arise, even unto death.

 

The Disappearance of Ancient Blood Variants

Some of the ancient blood group variants do not exist at all today. For example, the genome of a 45,000-year-old individual Homo sapiens from Siberia called Ust’Ishim, contained three variants of blood groups that are no longer present in humans today. This individual came from a “dead-end lineage” of Homo sapiens, whose genetic material was lost during the course of time.

Blood Types as an “Ancient Arsenal”

These blood groups that thrive in modern humans may have been an “ancient arsenal” against pathogens, enabling our ancestors to flourish in a wide range of environments. Yet many of the specific diseases these blood groups helped fight off have yet to be identified by scientists. The study emphasizes complexity both in the evolution of blood types and as a significant factor in the survival of humankind.

 

Future Directions: Probing Inherited Blood Diseases

This team of researchers is now looking at whether ancient genomes harbor mutations that contribute to inherited blood diseases, like beta thalassemia and sickle cell disease. The diseases are already thought to have ancient evolutionary roots, but the exact timing of their emergence is still little understood. “The question is, how far back do these mutations go?” says Stéphane Mazières, genetic anthropologist and lead researcher on the study.

 

Implications for Modern Medicine

These findings significantly enhance our knowledge of human evolution and also have applications to medicine today: for instance, the types of blood are crucial during transfusions and in pregnancy, while any insights into its ancient origin can apply to medical practice. Besides, the insight into genetics that underlines the ABO blood type might lead an investigator to discover a new path to fight some diseases that come up because of blood groups.

 

Conclusion

The story of the evolution of blood types is an intriguing one, full of the history of human adaptation. As ancient Homo sapiens left Africa to enter a whole new world of different environments, their blood types adapted to new challenges. These genetic changes reflect the resilience and ingenuity of our species, as well as the lasting impact of interactions with Neanderthals. The more genetic secrets of our ancestors are unveiled, the more one can learn to appreciate the complex play of forces at work as humanity made its journey across the globe.

At AHB Lab, we are committed to bringing you the latest in science and innovation. From how ancient humans evolved new blood types after leaving Africa to how much of your DNA actually comes from Neanderthals, we’re here to keep you in the know about the latest and greatest discoveries. Follow our channel for insights into the fascinating world of human evolution, genetics, and beyond!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More
公司最新訊息

你體內的「無名火」正在搞破壞!一招從源頭撲滅慢性發炎(淨火肽 Healtide® 機理大解密)

為什麼吃了消炎藥,身體的「火」還是滅不掉? 你是否經常遇到這樣的客戶反饋:消費者面對關節痠痛、過敏、腸胃不適或皮膚慢性暗沉,長期服用非類固醇消炎藥(NSAIDs)或塗抹類固醇,卻總是反覆發作、治標不治本 ?   現代醫學與功能生物學證實:90% 的慢性疾病與老化瓶頸,核心源頭都來自體內撲不滅的「慢性發炎」。 傳統生技產品或化學藥物的開發邏輯,大多著眼於抑制下游的 COX-1 或 COX-2 酵素 。用一個心智模型(Mental Model)來比喻:這就像火災發生時,你只是跑去「關掉煙霧探測器」,卻根本沒有沒收那個正在不斷點火的「打火機」! 長期下來,不僅無法根除發炎,化學藥物更可能增加肝腎與腸胃道的代謝負擔 。 市場正在尋找一種更高訊噪比、能「從源頭斷火」且安全無副作用的革命性生物素材。這正是富比積生物科技(AHB Lab)董事長莊國昇博士與研發團隊,成功推出第三代生物合成定序胜肽——淨火肽(Healtide®)的契機 。   淨火肽(Healtide®)的源頭阻斷機制 當人體受到刺激時,免疫系統的「巨噬細胞」會釋放 TNF-α(腫瘤壞死因子)與 IL-1β 等發炎細胞因子 。一旦失控,就會引發無差別攻擊正常組織的「細胞因子風暴」

Read More